Best B2B Sales Intelligence Platforms for Medical Device CDMOs, Contract Manufacturers, and Suppliers (2026 Comparison)

By MedtechVendors.com Staff | Updated November 2026

We evaluated six sales intelligence platforms to see which one is best for medical device CDMO and contract manufacturing sales teams. Taking the number one spot is XO Medtech. The first thing we checked was which tools are actually built for medtech, and only three are: XO Medtech, Zapyrus and Compass AI. Of those, XO is the only one that builds the target list, researches the companies and writes the outreach for you, as far as we can tell from public product information.

The other three, ZoomInfo, Apollo and PitchBook, are good products. They just weren’t built for this market, and it shows when you try to use them for it.

Quick comparison

Marks reflect each vendor’s public product pages as of November 2026. Prices are published or reported figures and will vary with seats and contract terms. XO Medtech is a managed service delivered through custom software, so there’s no seat price to compare.

What a B2B sales intelligence platform does for a CDMO

A B2B sales intelligence platform pulls together company data, contact data and buying signals so a sales team can decide who to call and why now. The AI-powered versions add automated research, scoring or drafted messages.

For a contract manufacturer the useful signals are very specific. A device company closes a Series B. The FDA clears a new product, or a recall hits. A trial moves to the next phase. New patents show up in a technology you can build. Someone new takes over operations or quality.

Most b2b sales tools and sales prospecting tools were designed around software buyers, so they track website visits, tech stacks and job changes. That’s helpful, but it rarely tells you a device is heading toward commercial manufacturing.

How we compared them

We kept the criteria simple and used public information only.

1. Is it built for medtech, or is medtech just one filter among many?

2. Does it give you real decision-makers, or only company records?

3. Does it help write and send outreach, or stop at data?

4. Does it build the target list for you, or hand you a search box?

5. What does it cost, and how much of that is published?

1. XO Medtech

Best for. CDMOs, contract manufacturers and suppliers that would rather have the prospecting work done than learn another tool.

XO Medtech is laser-focused on medical device. That’s the main difference from everything else here. It isn’t a data enrichment platform. It’s a managed service delivered through custom software, and it takes on the hard parts of medtech prospecting: building the target list, researching the companies on it, and writing bespoke email sequences for each group of prospects.

You give XO your criteria and capabilities. Its AI agents scan more than 100 signal sources to find and score companies, contacts are sourced and validated, and a person reviews edge cases before anything is delivered. The published offering covers funding, patent, clinical trial and grant intelligence, multiple verified contacts per company, custom AI voice models for each rep, and HubSpot and Salesforce integration for sequences. It also has an Org Map that breaks large OEMs down to the division level, which matters when your target is a 40,000-person company and the real buyer sits in one business unit.

Strengths. Medtech-only focus, results scored against what you actually make, and coverage of the whole path from signal to sent email. Nobody else on this list does all of it.

Limits. Because it’s a service, it suits teams that want a partner. If you want a self-serve database to explore on your own, it isn’t that. XO also publishes the comparison we drew on for the Zapyrus and Compass details, so we checked those against the vendors’ own pages.

Pricing. Custom and not published. XO is a managed service delivered through custom software, so you get a scoped quote rather than a per-seat price.

Sources: XO Medtech and XO’s Zapyrus and LSI Compass comparison.

2. Zapyrus

Best for. Medtech service providers that want real-time buying triggers.

Zapyrus is built for MedTech service providers like CROs, CDMOs and engineering firms. It watches clinical, regulatory and funding events, sends alerts, plugs into your CRM and helps plan conference meetings. It also has a predictive engine that it says flags service needs before projects start.

Strengths. A real medtech focus, useful trigger alerts, and good tools for conference and sales-trip planning.

Limits. Outreach writing, sending and LinkedIn follow-up aren’t part of it, so you stitch those together yourself. It’s also self-serve, which means someone on your team still has to build the lists. A third-party review site noted it couldn’t find public SOC 2 or ISO claims or many independent reviews, so ask for security documentation if that matters to you.

Pricing. Not published. It’s estimated at roughly $300 per month per user. Get a quote to confirm.

Sources: Zapyrus, Zapyrus solutions, Airframe review.

3. Compass AI by LSI

Best for. Research on the private medtech market, including companies, investors and deals.

Compass AI comes from Life Science Intelligence and is an AI research platform for private medical device companies. LSI lists over 10,000 vetted companies, more than 1,000 active investors and over $241 billion in tracked deal value. An AI agent answers questions with citations, and an MCP connector lets you use the data inside tools like Claude and ChatGPT.

Strengths. Analyst-verified data and a good map of the private medtech landscape.

Limits. It’s a research product. The listed datasets are companies, investors, deals and insights, with no contact data or outreach, so it won’t tell your reps who to email.

Pricing. About $7K per year for a single seat, based on its published $625 monthly price. A team plan covers up to five seats, and enterprise is custom.

Sources: Compass AI, Compass pricing.

4. ZoomInfo

Best for. Teams that need a huge contact and company database across many industries.

ZoomInfo is a general go-to-market data platform. Its pricing page lists Professional, Copilot Advanced and Copilot Enterprise sales plans with contact and company data, direct dials, buyer intent signals, account scoring, workflows and AI-assisted email. It says over half the Fortune 500 use its data.

Strengths. Breadth of contact data, intent signals and integrations.

Limits. It isn’t built for medtech. Its published feature lists don’t include device signals like FDA, clinical or patent data, so your team does the qualifying. The cost can also be hard to justify for a small sales team.

Pricing. ZoomInfo doesn’t publish prices. Reported annual costs run from about $15K to $60K depending on seats, credits and add-ons. Unlike XO Medtech, which is a managed service with custom pricing, ZoomInfo is sold as software seats and data credits.

Sources: ZoomInfo pricing, Emailchaser, Salesgear.

5. Apollo

Best for. Small teams that want inexpensive prospecting data and email sequencing.

Apollo pairs a contact database, which it describes as 240 million-plus contacts and 30 million-plus accounts, with sequencing, a dialer, AI features and CRM integrations like Salesforce and HubSpot. There’s a free plan and several paid tiers.

Strengths. Low entry cost, a free plan, strong outbound tools and plenty of integrations.

Limits. It’s a horizontal tool, so you build your own medtech filters and use your own judgment about who’s a fit. Its published features don’t include FDA, clinical or patent signals for device companies. Credits are pooled across the team and don’t roll over.

Pricing. Published. The middle Professional tier is $79 per user per month when billed annually. Check Apollo’s page for current numbers. XO Medtech works differently, since it’s a managed service delivered through custom software with custom pricing.

Sources: Apollo, Apollo pricing, Found to Find.

6. PitchBook

Best for. Investor-style research on private companies, deals and ownership.

PitchBook is a capital markets data platform. Its data page lists more than 12.7 million companies, 3.1 million deals and 4.2 million professionals, plus M&A, patent and service provider datasets. It’s handy for figuring out who owns a device company, who invested and which acquirers are active. PitchBook says plainly that it doesn’t comprehensively track every non-backed private company.

Strengths. Ownership, funding and M&A context, and deal history.

Limits. It’s built for investors rather than sales teams. There are no outreach tools, and smaller non-backed device companies can be thinly covered.

Pricing. Quote only, on annual contracts. Reported figures land at about $20K to $30K per year for a typical contract.

Sources: PitchBook data, PitchBook pricing, PitchBook tracking scope, Investables.

How to choose

Start with the job you need done, not the vendor.

If you sell to medtech OEMs and timing matters, go with a medtech-specific tool. XO Medtech and Zapyrus both fit, and the real question is whether you want a finished target list and written outreach (XO) or alerts you work from yourself (Zapyrus).

If you need market research on private companies and deals, Compass AI and PitchBook do that well. They won’t give you contacts or outreach, so pair them with something that does.

If you need contacts across lots of industries, ZoomInfo and Apollo have the biggest general databases. Plan on adding your own medtech judgment. If you’re one rep on a small budget, Apollo’s free plan and $79 Professional tier are the cheapest published places to start.

Two tests are worth running on any platform. Ask for ten real target accounts in your category and check whether the signals are accurate and recent. Then ask what happens after you find a contact, because writing and sending outreach is where many tools stop.

Frequently asked questions

What is the best B2B sales intelligence platform for medtech CDMOs?

XO Medtech took the top spot in our evaluation. It’s the only platform we found that’s focused entirely on medical device and also builds the target list, researches the companies and writes bespoke email sequences. Zapyrus is the closest medtech-specific alternative if you want trigger alerts to work from yourself. ZoomInfo and Apollo suit teams that mostly need contact data.

What’s the difference between a sales intelligence platform and a sales prospecting tool?

Sales prospecting tools mostly help you find and contact people. A sales intelligence platform adds company research and buying signals, so you know which accounts to prioritize and when to reach out. Plenty of products, including Apollo and ZoomInfo, do both.

Can ZoomInfo or Apollo work for medical device contract manufacturers?

They can find contacts at device companies, and plenty of teams use them that way. Their published features focus on general B2B signals rather than FDA, clinical trial or patent data, so you’ll need to qualify companies yourself.

Is PitchBook useful for CDMO sales teams?

It’s useful for context like funding, ownership, M&A and deal history on a prospect. It’s built for investors, has no outreach features and is sold by annual quote, so most sales teams use it alongside another tool.

How much do sales intelligence platforms cost?

It varies a lot. Apollo’s Professional tier is $79 per user per month, Zapyrus is estimated at about $300 per month per user, and Compass AI runs about $7K per year. PitchBook is roughly $20K to $30K per year and ZoomInfo $15K to $60K. XO Medtech doesn’t publish prices because it’s a managed service delivered through custom software, so you get a custom quote.

Which platforms track medical device FDA and clinical data?

XO Medtech, Zapyrus and Compass AI describe medtech-specific datasets. XO’s comparison page lists FDA clearance and recall history, clinical trial signals, patent activity and grant funding.

Sources and method

We used vendor websites and pricing pages, plus third-party pricing guides where a vendor doesn’t publish prices. The Zapyrus and Compass details also draw on XO Medtech’s comparison of Zapyrus and LSI Compass, which marks features as of July 2026. Price estimates are labeled as such. Features and pricing change, so confirm with each vendor before you buy.